A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
2017
International Journal of Molecular Sciences
Despite the substantial burden of illness in schizophrenia, there has been a discrepancy between the beneficial effects of an increased use of antipsychotic medications and achieving limited recovery or remission. Because the focus of the most common antipsychotic medications is on dopamine, which is associated with positive symptoms, there is an unmet need for patients with negative symptoms. Since cognitive and negative symptoms rather than positive symptoms are more closely associated with
doi:10.3390/ijms18040734
pmid:28358303
pmcid:PMC5412320
fatcat:x2lgscqsqbfkpjutjs7jwdabji